Becton Dickinson's revenue has grown by 5.0% a year over the last 5 years – slower than the median of the Health Care sector (+8.5%). The net margin in the last fiscal year was 7.7%, the sector median 13.9%. The 52-week high is 3.6% away (close of Nov 20, 2026).
Metrics from daily candles, as of Nov 20, 2026
· Extended universe
Live quote by TradingView
One click loads all TradingView content on this page. Data (including your IP address) is sent to TradingView, also to the USA. Privacy
Prices: TradingView (stock prices delayed).
Figures in the price bar from TradingView (mostly trailing 12 months) · our fundamental analysis uses the fiscal year
At a glance: figures and chart
2 strengths · 2 weaknesses · Fiscal year to Sep 30, 2025
Quality checks from the annual figures and, separately, the position of the price relative to the 200-day line. No overall score.
Quality5 of 8 criteria with data met
Growth4 of 7 criteria with data met
Dividend6 of 7 criteria with data met
Financial strength5 of 6 criteria with data met
Chart positionbelow200-day lineabovemore than 10% above – position relative to the 200-day line
Strengths well above the threshold
+EPS growth 5 years+16.5% per yearThreshold: above 5% per year · Distance +11.5 pp · Sector median +8.3% per year (47 stocks) · Fiscal year to Sep 30, 2025
+Equity ratio45.9%Threshold: above 30% · Distance +15.9 pp · Sector median 44.2% (63 stocks) · Fiscal year to Sep 30, 2025
Weaknesses well below the threshold
−Return on equity6.6%Threshold: above 15% · Distance −8.4 pp · Sector median 12.8% (54 stocks) · Fiscal year to Sep 30, 2025
−Piotroski F-Score5 of 9Threshold: at least 7 · Distance −2 points · Sector median 6 of 9 (47 stocks) · Fiscal year to Sep 30, 2025
On the radar
Position relative to the 200-day line: more than 10% above (as of Nov 20, 2026)
Net margin 7.7% – Threshold: above 10%, distance −2.3 pp (Fiscal year to Sep 30, 2025)
Free cash flow margin 12.2% – Threshold: above 10%, distance +2.2 pp (Fiscal year to Sep 30, 2025)
What we do not know
All criteria have data.
How is this made? · Created on Nov 22, 2026 from fixed rules · not investment advice
Load chart from TradingView
This transfers data (including your IP address) to TradingView, also to the USA. More in the Privacy policy.
Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself.Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself.Academy: 200-day line · RSI
About the company
Becton Dickinson (BD) is a major medical technology maker from New Jersey. It makes syringes, needles, catheters, infusion pumps and surgical products. Its biosciences and diagnostics business went to Waters in early 2026; since then BD has focused on medical products for hospitals and practices. As of Oct 12, 2026
As of Oct 12, 2026Fact sheet (from the annual report)Medical instruments · Franklin Lakes, USAfull fact sheet
BD is a global medical technology company that develops, manufactures and sells medical supplies and devices for healthcare institutions, physicians and the pharmaceutical industry. According to the report, the Biosciences and Diagnostic Solutions business was to be separated and combined with Waters; until then Life Sciences remained a separate segment. The offering ranges from syringes and needles to blood collection systems and products for vascular care, urology, oncology and surgery. Since October 2025 BD has been divided into new segments, including Medical Essentials, Connected Care and BioPharma Systems. In September 2024 BD acquired the Critical Care division of Edwards Lifesciences, now called Advanced Patient Monitoring.
This symbol belongs to the extended universe: we load daily candles only and show metrics, fundamentals and an overview – chart methods and Elliott analysis are not available for it.
Calculated automatically by fixed rules – not investment advice, check for yourself. How we analyze
Price performance at a glance
Last 30 trading days
Today+0.1%
7 days−2.4%
30 days+9.5%
1 year+42.8%
Day range (last trading day)
−0.7%Price at 28% of the range+1.8%
52-week range
−34.2%Price at 91% of the range+3.6%
Distance from the all-time high
−5.8%
Our own calculation from the exchange’s daily candles, as of Nov 20, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.
Chart analysis: trend by timeframe
Trend by timeframeFor each timeframe (week, day, 4 hours): up when the close is above the SMA 200, the EMA 20 above the EMA 50 and the structure shows higher highs and lows. Down the other way round, otherwise mixed. No score, no forecast.Example: Week up, day up, 4 hours mixed → not aligned.More in the Academy: Lesson trend and market structure
1Wweekly candles↗ up
Close above the SMA 200
EMA 20 above the EMA 50
higher highs and higher lows
Price above the EMA 20 · above the EMA 50
Week to Nov 20, 2026
1Ddaily candles↗ up
Close above the SMA 200
EMA 20 above the EMA 50
higher highs and higher lows
Price above the EMA 20 · above the EMA 50
Daily candle of Nov 20, 2026
4H4-hour candles– not available
No value on 4 hours (too few or no checked 4-hour candles).
Rule per timeframe: up = close above the SMA 200, EMA 20 above the EMA 50 and higher highs and lows; down = everything the other way round; otherwise mixed. Completed candles only, no overall score, no forecast. In the screener: all three up →
What does the daily chart show right now – line by line, without an overall verdict?
Technicals in plain words
Technicals in plain wordsFour lines on the daily chart – trend, momentum, volume, volatility –, each with its metric and threshold. We do not add the lines up or give a grade; they describe the price history so far.Example: RSI 64 → between 30 and 70, neither overbought nor oversold.More in the Academy: Lesson reading the RSI
Over the last 3 months it ran stronger than the S&P 500 and stronger than the median of the sector “Health Care”.
vs. S&P 500 · 3 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
stronger
vs. S&P 500 · 6 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
stronger
vs. sector · 3 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
stronger
Trendabove SMA 200Price above the 200-day line – above it the long-term trend counts as up; ADX above 25 – a pronounced trend.
MomentumneutralRSI between 30 and 70 – neither overbought nor oversold; MACD line fell below its signal line in the last 5 trading days.
Volumenot elevatedVolume on the last trading day below 1.5 times the average of up to 50 trading days before – not elevated.
VolatilitynormalTypical daily range (ATR 14) between 2 and 4% of the price – normal.
The figures behind it – distance to the line, RSI, volume, volatility and relative strength in percentage points – are visible with a free account.Sign up free
More depth
How we read the lines
Each line stands on its own – we do not add them up and give no grade.
Trend: the 200-day line is the average of the last 200 closing prices. The ADX (14) measures how pronounced a trend is, not its direction: below 20 hardly any trend, above 25 pronounced.
Momentum: the RSI (14) lies between 0 and 100; below 30 it counts as oversold, above 70 as overbought. The MACD (12/26) compares two averages, the signal line (9) smooths it.
Volume: shares traded on the last trading day divided by the average of up to 50 trading days before; from 1.5x elevated, from 2x unusually high, from 3x very high.
Volatility: typical daily range (ATR 14) as a percentage of the price; below 2% calm, 2 to 4% normal, above 4% high. Squeeze = Bollinger Bands as narrow as on at most a fifth of the last 120 trading days.
Relative strength: the stock’s price change minus that of the benchmark over the same period (3 months = 91 days, 6 months = 182 days), in percentage points, from completed daily candles. Benchmark: the S&P 500 (ETF SPY) or the median of the stocks of the same sector in our selection (at least 5 others with a candle on the same day). Dividends are not included.
Against the sector median over 6 months: ran stronger.
All figures describe the price history so far – they do not say what happens next.
As of: daily candle of Nov 20, 2026 · from our daily candles
How did this asset do in each calendar month over the last 10 years?
Seasonality
SeasonalityHow an asset did in each calendar month over the last 10 years: monthly return from the last trading day of the previous month to the last one of the month, without dividends, completed months only. Past performance, not a forecast.Example: Example: November higher in 7 of 10 years → describes past years, not the next November.More in the Academy: Lesson seasonality
In November, the stock closed higher in 7 of 10 years – the S&P 500 in 9 of 10.
Years higher in NovemberSeasonalityHow an asset did in each calendar month over the last 10 years: monthly return from the last trading day of the previous month to the last one of the month, without dividends, completed months only. Past performance, not a forecast.Example: Example: November higher in 7 of 10 years → describes past years, not the next November.More in the Academy: Lesson seasonality
7 of 10
2016 to 2025
S&P 500 in November
9 of 10
years higher, same years as above (ETF SPY)
Months mostly higher
7 of 12
Calendar months that closed higher in more than half of the years
You can see the median and range per month in percent with a free account.Sign up free
8/10Jan
3/10Feb
6/10Mar
5/10Apr
2/10May
7/10Jun
9/10Jul
7/10Aug
0/10Sep
4/10Oct
7/10Nov
6/10Dec
January: higher in 8 of 10 years
February: higher in 3 of 10 years
March: higher in 6 of 10 years
April: higher in 5 of 10 years
May: higher in 2 of 10 years
June: higher in 7 of 10 years
July: higher in 9 of 10 years
August: higher in 7 of 10 years
September: higher in 0 of 10 years
October: higher in 4 of 10 years
November (current month): higher in 7 of 10 years
December: higher in 6 of 10 years
Past performance, not a forecast · Bar = share of years higher, line = half · Price return without dividendsMore depth
How we calculate
Monthly return = closing price on the last trading day of the month ÷ closing price on the last trading day of the previous month − 1. Price return without dividends.
Only completed months count, never the current one. If the candle of the last trading day is missing, the month does not count.
For each calendar month the last 10 years in which it has ended; from 8 years with a value we show the median, years higher and the range. “Higher” means: return above 0.0%.
Past performance, not a forecast: the figures describe earlier years and do not tell how the next month will go.
By calendar month (● = current month)
Month
Years higher
January
8 of 10
February
3 of 10
March
6 of 10
April
5 of 10
May
2 of 10
June
7 of 10
July
9 of 10
August
7 of 10
September
0 of 10
October
4 of 10
November ●
7 of 10
December
6 of 10
Through October 2026 (last completed month) · from our daily candles
Fundamental analysis
SEC filing (10-K, 10-Q)Required reports of listed companies to the US Securities and Exchange Commission (SEC): 10-K is the annual report, 10-Q the quarterly report, 20-F the annual report of foreign companies. We show the figures of the first filing.Example: 10-K for the fiscal year ending Sep 27, 2025, filed on Oct 31, 2025.More in the Academy: Lesson revenue, profit and margin
Becton Dickinson · Sector Health Care · amounts in USD
Source: SEC filings, As of Nov 25, 2025.
Investor typeInvestor type (“lens”)You choose which style comes first: dividends, valuation, growth, quality or trading. Screener and stock page then show suggestions and “For you first”, with an account also matching columns and order. The lens unlocks nothing and changes no matches.Example: Lens “Dividends” → on the stock page first the streak without a cut, growth and cover of the dividend.More in the Academy: Guide fundamental analysis
For you firstDividend
The dividend per share was never cut as far as our annual data goes (10 years in a row); free cash flow per share covers it 2.2x.
Four angles on the annual figures. Each check counts how many disclosed criteria are met – criteria without data do not count. The bars show where the company ranks on each figure among the stocks we cover and within its sector.
✓met: Profit in each of the last 5 fiscal years5 of 5
✓met: Free cash flow positive in each of the last 3 fiscal years3 of 3
✓met: Equity ratio above 30%45.9%
Gross margin
45.4%Fiscal year 2025
All49medium
Rank 49 of 100: higher than 49% of 370 peers (All). medium.
Sector30weak
Rank 30 of 100: higher than 30% of 49 peers (Sector). weak.
Median Health Care: 61.8%
Share of revenue left after the direct cost of the products sold.
Operating margin
11.8%Fiscal year 2025
All40medium
Rank 40 of 100: higher than 40% of 470 peers (All). medium.
Sector34medium
Rank 34 of 100: higher than 34% of 54 peers (Sector). medium.
Median Health Care: 17.0%
Operating income divided by revenue: what the core business earns before interest and taxes.
Net margin
7.7%Fiscal year 2025
All35medium
Rank 35 of 100: higher than 35% of 584 peers (All). medium.
Sector31weak
Rank 31 of 100: higher than 31% of 63 peers (Sector). weak.
Median Health Care: 12.9%
Profit after all costs, interest and taxes divided by revenue.
Return on equity
6.6%Fiscal year 2025
All24weak
Rank 24 of 100: higher than 24% of 544 peers (All). weak.
Sector19weak
Rank 19 of 100: higher than 19% of 54 peers (Sector). weak.
Median Health Care: 12.8%
Net income divided by equity at fiscal year end.
Return on assets
3.0%Fiscal year 2025 (total assets at year end)
All35medium
Rank 35 of 100: higher than 35% of 594 peers (All). medium.
Sector21weak
Rank 21 of 100: higher than 21% of 63 peers (Sector). weak.
Median Health Care: 6.6%
Net income divided by total assets at fiscal year end.
Equity ratio
45.9%Fiscal year 2025
All64medium
Rank 64 of 100: higher than 64% of 595 peers (All). medium.
Sector53medium
Rank 53 of 100: higher than 53% of 63 peers (Sector). medium.
Median Health Care: 44.2%
Equity as a share of total assets. Usually low for banks.
Free cash flow margin
12.2%Fiscal year 2025
All52medium
Rank 52 of 100: higher than 52% of 465 peers (All). medium.
Sector37medium
Rank 37 of 100: higher than 37% of 61 peers (Sector). medium.
Median Health Care: 14.5%
Free cash flow divided by revenue.
Free cash flow
2.7B USDFiscal year 2025
Operating cash flow minus capital expenditure on property and equipment.
Growth 4 of 7 met
✗not met: Over 3 years, revenue grew by more than 5% per year+5.0%
✗not met: Over 5 years, revenue grew by more than 5% per year+5.0%
✓met: Over 10 years, revenue grew by more than 5% per year+7.8%
✗not met: Over 3 years, EPS grew by more than 5% per year−0.3%
✓met: Over 5 years, EPS grew by more than 5% per year+16.5%
✓met: Revenue rose in at least 4 of the last 5 fiscal years4 of 5
✓met: Revenue rose in the last fiscal year+8.2%
Revenue growth 3 years
+5.0%per year
All44medium
Rank 44 of 100: higher than 44% of 578 peers (All). medium.
Sector49medium
Rank 49 of 100: higher than 49% of 62 peers (Sector). medium.
Median Health Care: +5.1%
Average growth per year over 3 fiscal years.
Revenue growth 5 years
+5.0%per year
All27weak
Rank 27 of 100: higher than 27% of 549 peers (All). weak.
Sector23weak
Rank 23 of 100: higher than 23% of 60 peers (Sector). weak.
Median Health Care: +7.8%
Average growth per year over 5 fiscal years.
Revenue growth 10 years
+7.8%per year
All60medium
Rank 60 of 100: higher than 60% of 412 peers (All). medium.
Sector37medium
Rank 37 of 100: higher than 37% of 50 peers (Sector). medium.
Median Health Care: +9.3%
Average growth per year over 10 fiscal years.
EPS growth 3 years
−0.3%per year
All31weak
Rank 31 of 100: higher than 31% of 437 peers (All). weak.
Sector31weak
Rank 31 of 100: higher than 31% of 54 peers (Sector). weak.
Median Health Care: +5.0%
Growth of earnings per share per year, adjusted for stock splits.
EPS growth 5 years
+16.5%per year
All68strong
Rank 68 of 100: higher than 68% of 399 peers (All). strong.
Sector78strong
Rank 78 of 100: higher than 78% of 47 peers (Sector). strong.
Median Health Care: +8.3%
Growth of earnings per share per year, adjusted for stock splits.
EPS growth 10 years
+5.7%per year
All32weak
Rank 32 of 100: higher than 32% of 375 peers (All). weak.
Sector32weak
Rank 32 of 100: higher than 32% of 46 peers (Sector). weak.
Median Health Care: +9.3%
Growth of earnings per share per year, adjusted for stock splits.
Dividend 6 of 7 met
✓met: Pays a dividend4.16 USD
✗not met: Payout ratio at most 60% of earnings71%
✓met: Dividend paid in each of the last 5 fiscal years5 of 5
✓met: Dividend per share never lowered in the last 5 fiscal yearsDividend per share as filed with the SEC, including special dividends; a one-off higher prior year does not count as a cut.never
✓met: Dividend per share higher than 5 years ago+5.7%
✓met: Free cash flow per share covers the dividend2.2x
✓met: Dividends paid over the last 5 years covered by free cash flow43% of free cash flow
Payout ratio
71%Fiscal year 2025
Dividend per share divided by earnings per share.
Dividend growth 5 years
+5.7%per year
All37medium
Rank 37 of 100: higher than 37% of 321 peers (All). medium.
Sector34medium
Rank 34 of 100: higher than 34% of 31 peers (Sector). medium.
Median Health Care: +6.6%
Growth of the dividend per share per year.
Free cash flow coverage
2.2xFiscal year 2025
Free cash flow per share divided by dividend per share. From 1x the dividend is covered.
Financial strength 5 of 6 met
✗not met: Piotroski F-Score at least 7 of 95 of 9
✓met: Long-term debt no higher than equity0.69
✓met: Current assets cover current liabilities1.11
✓met: Positive equity25.4B USD
✓met: In 5 years, share count up by at most 5%+2.2%
✓met: Free cash flow positive in the last fiscal year2.7B USD
Piotroski F-Score
5 of 9Fiscal year 2025
All22weak
Rank 22 of 100: higher than 22% of 310 peers (All). weak.
Sector17weak
Rank 17 of 100: higher than 17% of 47 peers (Sector). weak.
Median Health Care: 6.0 of 9
Nine yes/no tests on profit, cash flow, debt, liquidity and efficiency compared with the prior year.
Debt / equity
0.69at fiscal year end
All46medium
Rank 46 of 100: lower than 46% of 486 peers (All). medium.
Sector43medium
Rank 43 of 100: lower than 43% of 50 peers (Sector). medium.
Median Health Care: 0.66
Long-term financial debt divided by equity.
Liquidity (current ratio)
1.11at fiscal year end
All37medium
Rank 37 of 100: higher than 37% of 513 peers (All). medium.
Sector21weak
Rank 21 of 100: higher than 21% of 63 peers (Sector). weak.
Median Health Care: 1.58
Current assets divided by current liabilities.
Change in share count
+2.2%in 5 years
All32weak
Rank 32 of 100: lower than 32% of 507 peers (All). weak.
Sector18weak
Rank 18 of 100: lower than 18% of 59 peers (Sector). weak.
Median Health Care: −4.3%
Change in diluted share count. Negative = share buybacks, positive = new shares.
The 9 criteria of the Piotroski F-Score
✓met: Profit in the last fiscal year (positive return on assets)
✓met: Positive operating cash flow
✗not met: Return on assets higher than the prior year
✓met: Operating cash flow higher than net income
✗not met: Long-term debt relative to total assets fell
✗not met: Liquidity (current assets / current liabilities) rose
✓met: No additional shares (diluted share count did not rise)
✓met: Gross margin higher than the prior year
✗not met: Revenue relative to total assets higher than the prior year
Last fiscal year compared with the one before. Returns and revenue per total assets use total assets at the start of the year; leverage = long-term financial debt divided by total assets at year end; new shares via the average diluted share count.
Price-based criteria (P/E, dividend yield) are shown to signed-in users.
Computed automatically from SEC annual reports – not investment advice. Describes the reported figures; points are not a rating of the stock. Rank 0–100 against the 239 stocks we cover and against the sector (from 5 peers); the stronger side is always on the right.
In short
Light yellow: Revenue grew over 5 years (+5.0% per year), more slowly than the sector median.
Light green: Net income (total) grew over 5 years (+13.9% per year), at least as fast as the sector median; per share +16.5% per year.
Light yellow: Net margin 7.7%, below the sector median (13.9%).
Light green: Debt not higher than usual in the sector.
Light green: Profit in each of the last 10 fiscal years.
Light yellow: High payout ratio (71% of earnings).
Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.
RevenueNet incomeNet margin (below)in USD
010B20B30B
2016Fiscal year 2016 (Oct 1, 2015 – Sep 30, 2016): Revenue 12.5B USD · Net income 976.0M USD · Net margin 7.8%
2017Fiscal year 2017 (Oct 1, 2016 – Sep 30, 2017): Revenue 12.1B USD · Net income 1.1B USD · Net margin 9.1%
2018Fiscal year 2018 (Oct 1, 2017 – Sep 30, 2018): Revenue 16.0B USD · Net income 311.0M USD · Net margin 1.9%
2019Fiscal year 2019 (Oct 1, 2018 – Sep 30, 2019): Revenue 17.3B USD · Net income 1.2B USD · Net margin 7.1%
2020Fiscal year 2020 (Oct 1, 2019 – Sep 30, 2020): Revenue 17.1B USD · Net income 874.0M USD · Net margin 5.1%
2021Fiscal year 2021 (Oct 1, 2020 – Sep 30, 2021): Revenue 20.2B USD · Net income 2.1B USD · Net margin 10.3%
2022Fiscal year 2022 (Oct 1, 2021 – Sep 30, 2022): Revenue 18.9B USD · Net income 1.8B USD · Net margin 9.4%
2023Fiscal year 2023 (Oct 1, 2022 – Sep 30, 2023): Revenue 19.4B USD · Net income 1.5B USD · Net margin 7.7%
2024Fiscal year 2024 (Oct 1, 2023 – Sep 30, 2024): Revenue 20.2B USD · Net income 1.7B USD · Net margin 8.4%
2025Fiscal year 2025 (Oct 1, 2024 – Sep 30, 2025): Revenue 21.8B USD · Net income 1.7B USD · Net margin 7.7%
Margin
7.8%9.1%1.9%7.1%5.1%10%9.4%7.7%8.4%7.7%
RevenueNet incomeNet margin (below)in USD
02B4B6B
Q3/23Quarter Q3/23 (Jul 1, 2023 – Sep 30, 2023): Revenue 5.1B USD · Net income 108.0M USD · Net margin 2.1% · Q4 derived (year minus 9 months), may be distorted by restatements
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Revenue 4.7B USD · Net income 281.0M USD · Net margin 6.0%
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Revenue 5.0B USD · Net income 537.0M USD · Net margin 10.6%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Revenue 5.0B USD · Net income 487.0M USD · Net margin 9.8%
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Revenue 5.4B USD · Net income 400.0M USD · Net margin 7.4% · Q4 derived (year minus 9 months), may be distorted by restatements
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Revenue 5.2B USD · Net income 303.0M USD · Net margin 5.9%
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Revenue 5.3B USD · Net income 308.0M USD · Net margin 5.8%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Revenue 5.5B USD · Net income 574.0M USD · Net margin 10.4%
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Revenue 5.9B USD · Net income 493.0M USD · Net margin 8.4% · Q4 derived (year minus 9 months), may be distorted by restatements
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Revenue 5.3B USD · Net income 382.0M USD · Net margin 7.3%
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Revenue 4.7B USD · Net income −311.0M USD · Net margin −6.6%
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Revenue 5.0B USD · Net income 377.0M USD · Net margin 7.6%
Margin
2.1%6.0%11%9.8%7.4%5.9%5.8%10%8.4%7.3%−6.6%7.6%
Earnings per shareUSD per share
02.004.006.008.00
2016Fiscal year 2016 (Oct 1, 2015 – Sep 30, 2016): Earnings per share 4.49 USD
2017Fiscal year 2017 (Oct 1, 2016 – Sep 30, 2017): Earnings per share 4.60 USD
2018Fiscal year 2018 (Oct 1, 2017 – Sep 30, 2018): Earnings per share 0.60 USD
2019Fiscal year 2019 (Oct 1, 2018 – Sep 30, 2019): Earnings per share 3.94 USD
2020Fiscal year 2020 (Oct 1, 2019 – Sep 30, 2020): Earnings per share 2.71 USD
2021Fiscal year 2021 (Oct 1, 2020 – Sep 30, 2021): Earnings per share 6.85 USD
2022Fiscal year 2022 (Oct 1, 2021 – Sep 30, 2022): Earnings per share 5.88 USD
2023Fiscal year 2023 (Oct 1, 2022 – Sep 30, 2023): Earnings per share 4.94 USD
2024Fiscal year 2024 (Oct 1, 2023 – Sep 30, 2024): Earnings per share 5.86 USD
2025Fiscal year 2025 (Oct 1, 2024 – Sep 30, 2025): Earnings per share 5.82 USD
Earnings per shareUSD per share
−2.00−1.0001.002.00
Q3/23Quarter Q3/23 (Jul 1, 2023 – Sep 30, 2023): Earnings per share not reported separately for Q4
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Earnings per share 0.96 USD
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Earnings per share 1.85 USD
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Earnings per share 1.68 USD
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Earnings per share not reported separately for Q4
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Earnings per share 1.04 USD
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Earnings per share 1.07 USD
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Earnings per share 2.00 USD
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Earnings per share not reported separately for Q4
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Earnings per share 1.34 USD
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Earnings per share −1.11 USD
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Earnings per share 1.37 USD
Dividend per sharePayout ratio (below)USD per share
02.004.006.00
2016Fiscal year 2016 (Oct 1, 2015 – Sep 30, 2016): Dividend per share 2.64 USD · Payout ratio 58.8%
2017Fiscal year 2017 (Oct 1, 2016 – Sep 30, 2017): Dividend per share 2.92 USD · Payout ratio 63.5%
2018Fiscal year 2018 (Oct 1, 2017 – Sep 30, 2018): Dividend per share 3.00 USD · Payout ratio 500.0%
2019Fiscal year 2019 (Oct 1, 2018 – Sep 30, 2019): Dividend per share 3.08 USD · Payout ratio 78.2%
2020Fiscal year 2020 (Oct 1, 2019 – Sep 30, 2020): Dividend per share 3.16 USD · Payout ratio 116.6%
2021Fiscal year 2021 (Oct 1, 2020 – Sep 30, 2021): Dividend per share 3.32 USD · Payout ratio 48.5%
2022Fiscal year 2022 (Oct 1, 2021 – Sep 30, 2022): Dividend per share 3.48 USD · Payout ratio 59.2%
2023Fiscal year 2023 (Oct 1, 2022 – Sep 30, 2023): Dividend per share 3.64 USD · Payout ratio 73.7%
2024Fiscal year 2024 (Oct 1, 2023 – Sep 30, 2024): Dividend per share 3.80 USD · Payout ratio 64.8%
2025Fiscal year 2025 (Oct 1, 2024 – Sep 30, 2025): Dividend per share 4.16 USD · Payout ratio 71.5%
Ratio
59%63%500%78%117%48%59%74%65%71%
Dividend per sharePayout ratio (below)USD per share
00.501.001.50
Q3/23Quarter Q3/23 (Jul 1, 2023 – Sep 30, 2023): Dividend per share not available · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Dividend per share 0.95 USD · Payout ratio 99.0%
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Dividend per share 0.95 USD · Payout ratio 51.4%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Dividend per share 0.95 USD · Payout ratio 56.5%
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Dividend per share not available · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Dividend per share 1.04 USD · Payout ratio 100.0%
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Dividend per share 1.04 USD · Payout ratio 97.2%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Dividend per share 1.04 USD · Payout ratio 52.0%
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Dividend per share not available · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Dividend per share 1.05 USD · Payout ratio 78.4%
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Dividend per share 1.05 USD · Payout ratio not available
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Dividend per share 1.05 USD · Payout ratio 76.6%
Ratio
99%51%57%100%97%52%78%77%
Fiscal year 2025 (Oct 1, 2024 – Sep 30, 2025): Revenue 21.8B USD · Net income 1.7B USD · Net margin 7.7%
How has it gone since the last annual report?
Trailing 12 months and quarters
Trailing 12 monthsFigures for the latest twelve months: fiscal year plus the months since it ended minus the same months a year earlier, each from the first SEC filing. More current than the fiscal year, but not audited. P/E, PEG and the checks still use the fiscal year.Example: Fiscal year $400M, 9 months after it $330M, same 9 months a year earlier $300M → 400 + 330 − 300 = $430M.More in the Academy: Lesson trailing twelve months
Revenue in the quarter to Jun 2026 +5.4% vs. the same quarter a year earlier; grown for 14 quarters in a row. Prior-year figures restated after a spin-off or divestiture – so no trailing 12-month figures; the quarterly comparison uses the restated prior-year figures.
Quarterly revenue vs. a year earlierQuarter vs. the same quarter a year earlierA quarter compared with the same quarter a year earlier – so seasonal business does not distort the comparison. The 4th quarter is fiscal year minus 9 months. A quarter can contain one-off effects; if the year-ago quarter was weak, the increase looks larger.Example: Revenue in the quarter to Sep 2026 $108M, quarter to Sep 2025 $100M → +8%.More in the Academy: Lesson trailing twelve months
+5.4%
prior year restated
Quarterly earnings vs. a year earlierQuarter vs. the same quarter a year earlierA quarter compared with the same quarter a year earlier – so seasonal business does not distort the comparison. The 4th quarter is fiscal year minus 9 months. A quarter can contain one-off effects; if the year-ago quarter was weak, the increase looks larger.Example: Revenue in the quarter to Sep 2026 $108M, quarter to Sep 2025 $100M → +8%.More in the Academy: Lesson trailing twelve months
−34.3%
prior year restated
More depth
By quarter (latest first, amounts in USD)
Quarter
Revenue
vs. year ago
Net income
Margin
Apr–Jun 26²
5.0B
+5.4%
377.0M
7.6%
Jan–Mar 26²
4.7B
+5.2%
−311.0M
−6.6%
Oct–Dec 25
5.3B
+1.6%
382.0M
7.3%
Jul–Sep 25*
5.9B
+8.4%
493.0M
8.4%
Apr–Jun 25
5.5B
+10.4%
574.0M
10.4%
Jan–Mar 25
5.3B
+4.5%
308.0M
5.8%
Oct–Dec 24
5.2B
+9.8%
303.0M
5.9%
Jul–Sep 24*
5.4B
+6.9%
400.0M
7.4%
Trailing 12 months = last fiscal year + the period since the start of the current fiscal year − the same period a year earlier, each from the first filing. P/E, PEG and the quality checks still use the last fiscal year.
Each quarter is compared with the same quarter a year earlier.
* derived: fiscal year minus the first 9 months.
² Year-ago quarter restated after a spin-off or divestiture – compared with the restated figure from the same report.
As of: quarter to Jun 30, 2026, filed on Aug 6, 2026 · Source: SEC filings (10-Q, 10-K)
Does the profit arrive as cash?
Earnings quality
Profit is backed by cash; interest is covered.
Cash flow ÷ profitCash flow ÷ profitOperating cash flow divided by group profit. From 1.0, at least as much cash came in as profit was reported; below that, profit may sit in receivables or inventories, and non-cash gains or one-off payments also push the ratio down. Depreciation and stock-based pay lift it.Example: Operating cash flow €120m, group profit €100m → 1.20x.More in the Academy: Lesson earnings quality
2.04x
0.81.0
backed from 1.0 · 3 years: 2.11x
Interest coverageInterest coverageOperating income divided by interest expense: how many times the core business earns its interest. From 5x we count interest as well covered, below 2x as thinly covered.Example: Operating income €50m, interest expense €5m → 10.0x.More in the Academy: Lesson earnings quality
4.2x
25
well covered from 5 · 3 years: 4.4x
Tax rateTax rateIncome taxes divided by profit before tax, in percent. If the SEC data lack it, we approximate it as group profit plus taxes; minority interests, discontinued operations, one-off items and tax credits can shift the rate.Example: Taxes €21m, net income €79m → 21 : 100 = 21%.More in the Academy: Lesson earnings quality
10.8%
for information only · 3 years: 11.4%
More depth
Calculation for fiscal year 2025
Operating cash flow 3.4B USD ÷ Net income 1.7B USD = 2.04x
How it is rated: cash flow ÷ profit from 1.0 “backed by cash”, below 0.8 “profit well above the cash coming in”; interest coverage from 5 “well covered”, below 2 “thinly covered”. The tax rate is only shown.
Cash flow ÷ profit uses group profit incl. minority interests, because cash flow also covers the whole group. Profit before tax as reported to the SEC, otherwise approximated. “3 years” = sums of the last three fiscal years – only if every year is reported and the figures have the same origin; for cash flow only with a profit in every year.
As of fiscal year 2025 · Source: SEC filings
How even were the last years?
Consistency
In 10 fiscal years no loss year and 3 years with lower revenue.
Loss yearsLoss yearsFiscal years that ended with a loss on the bottom line (net income below zero). Few loss years over a long period show how evenly a company has earned so far – they say nothing about the future.Example: Loss only in fiscal year 2020 → 1 of 10.More in the Academy: Lesson revenue, profit and margin
0 of 10
net income below zero
Years with lower revenueYear with lower revenueA fiscal year in which revenue was lower than in the prior year. Only years for which the prior year’s revenue is also reported are counted.Example: Revenue 100 → €96m → one year with lower revenue.More in the Academy: Lesson revenue, profit and margin
3 of 10
revenue below the prior year
Net margin rangeNet margin rangeHighest minus lowest net margin of the fiscal years shown, in percentage points. A small range means the share of profit in revenue stayed similar over the years.Example: Net margins between 18.2% and 26.4% → range 8.2 percentage points.More in the Academy: Lesson revenue, profit and margin
8.4 percentage points
from 1.9% to 10.3%
▾▾▾20162025Net margin by fiscal year · ▾ revenue below the prior yearMore depth
By fiscal year
FY
Revenue vs. prior year
Net margin
2025
+8.2%
7.7%
2024
+4.2%
8.4%
2023
+2.7%
7.7%
2022
−6.8%
9.4%
2021
+18.3%
10.3%
2020
−1.0%
5.1%
2019
+8.2%
7.1%
2018
+32.2%
1.9%
2017
−3.1%
9.1%
2016
+21.4%
7.8%
Loss year: net income below zero. Lower revenue: revenue below the prior year. Range: highest minus lowest net margin; margins beyond ±200% do not count. No score – only the reported figures.
As of fiscal years 2016–2025 · Source: SEC filings
Figures over time
Where the money of a fiscal year goes and how margins, returns, balance sheet, cash flow and share count developed over up to 10 years. Each chart has one sentence saying what the trend shows.
Money flow in fiscal year 2025
Of 100 USD of revenue, 45.4 USD gross profit, 11.8 USD operating income and 7.7 USD net income remained.
2016Fiscal year 2016: Operating cash flow 2.6B USD · Capital expenditure 693.0M USD · Free cash flow 1.9B USD
2017Fiscal year 2017: Operating cash flow 2.6B USD · Capital expenditure 727.0M USD · Free cash flow 1.8B USD
2018Fiscal year 2018: Operating cash flow 2.9B USD · Capital expenditure 895.0M USD · Free cash flow 2.0B USD
2019Fiscal year 2019: Operating cash flow 3.3B USD · Capital expenditure 957.0M USD · Free cash flow 2.4B USD
2020Fiscal year 2020: Operating cash flow 3.5B USD · Capital expenditure 810.0M USD · Free cash flow 2.7B USD
2021Fiscal year 2021: Operating cash flow 4.6B USD · Capital expenditure 1.2B USD · Free cash flow 3.4B USD
2022Fiscal year 2022: Operating cash flow 2.5B USD · Capital expenditure 973.0M USD · Free cash flow 1.5B USD
2023Fiscal year 2023: Operating cash flow 3.0B USD · Capital expenditure 874.0M USD · Free cash flow 2.1B USD
2024Fiscal year 2024: Operating cash flow 3.8B USD · Capital expenditure 725.0M USD · Free cash flow 3.1B USD
2025Fiscal year 2025: Operating cash flow 3.4B USD · Capital expenditure 760.0M USD · Free cash flow 2.7B USD
Share count
The share count rose in 5 years by 2.2% – more new shares were issued than repurchased (dilution).
Diluted share count
0100M200M300M
2016Fiscal year 2016: Diluted share count 217.5M
2017Fiscal year 2017: Diluted share count 223.6M
2018Fiscal year 2018: Diluted share count 264.6M
2019Fiscal year 2019: Diluted share count 274.8M
2020Fiscal year 2020: Diluted share count 282.4M
2021Fiscal year 2021: Diluted share count 292.1M
2022Fiscal year 2022: Diluted share count 287.4M
2023Fiscal year 2023: Diluted share count 288.4M
2024Fiscal year 2024: Diluted share count 291.0M
2025Fiscal year 2025: Diluted share count 288.5M
From annual reports filed with the SEC (10-K, 20-F, 40-F) as first reported, share count adjusted for splits; obvious filing errors (e.g. wrong unit, outliers against both neighbouring years) are hidden. Describes the reported figures – not investment advice.
Metrics chart
Metrics chartUp to three metrics stacked, each with its own axis, over the same fiscal years. Optionally a second stock (dashed or hatched) and today’s sector median as a mark in the latest year – we do not have earlier medians.Example: Revenue rises, net margin falls, share count falls → more business, less profit per unit of revenue, fewer shares (mostly through buybacks).More in the Academy: Guide fundamental analysis
Up to three metrics stacked over the same fiscal years – so you see at a glance whether they rise together or drift apart. Point at a year to read it in every panel.
Net margin
The net margin rose in 5 years from 5.1% to 7.7%.
BDXSector today 13.2%Mark in the latest year: today’s median of the Health Care sector as in the sector comparison (each latest fiscal year). We do not have earlier medians.
0%5%10%15%
2016Fiscal year 2016: BDX 7.8%
2017Fiscal year 2017: BDX 9.1%
2018Fiscal year 2018: BDX 1.9%
2019Fiscal year 2019: BDX 7.1%
2020Fiscal year 2020: BDX 5.1%
2021Fiscal year 2021: BDX 10.3%
2022Fiscal year 2022: BDX 9.4%
2023Fiscal year 2023: BDX 7.7%
2024Fiscal year 2024: BDX 8.4%
2025Fiscal year 2025: BDX 7.7% · Sector today 13.2%
Return on equity
Return on equity rose in 5 years from 3.7% to 6.6%.
BDXSector today 13.6%
0%5%10%15%
2016Fiscal year 2016: BDX 12.8%
2017Fiscal year 2017: BDX 8.5%
2018Fiscal year 2018: BDX 1.5%
2019Fiscal year 2019: BDX 5.8%
2020Fiscal year 2020: BDX 3.7%
2021Fiscal year 2021: BDX 8.8%
2022Fiscal year 2022: BDX 7.0%
2023Fiscal year 2023: BDX 5.8%
2024Fiscal year 2024: BDX 6.6%
2025Fiscal year 2025: BDX 6.6% · Sector today 13.6%
Free cash flow margin
The free cash flow margin fell in 5 years from 15.9% to 12.2%.
BDXSector today 14.7%
0%5%10%15%20%
2016Fiscal year 2016: BDX 14.9%
2017Fiscal year 2017: BDX 15.1%
2018Fiscal year 2018: BDX 12.3%
2019Fiscal year 2019: BDX 13.7%
2020Fiscal year 2020: BDX 15.9%
2021Fiscal year 2021: BDX 16.9%
2022Fiscal year 2022: BDX 7.9%
2023Fiscal year 2023: BDX 10.9%
2024Fiscal year 2024: BDX 15.5%
2025Fiscal year 2025: BDX 12.2% · Sector today 14.7%
Source: SEC filings, fiscal years up to Sep 30, 2025. The same figures as in the sections of this page, per fiscal year as first reported. Describes the reported figures – not investment advice.
How reliable is the dividend?
Dividend at a glance
The dividend per share was never cut as far as our annual data goes (10 years in a row); free cash flow per share covers it 2.2x.
Years without a cutYears without a dividend cutHow many fiscal years in a row up to the latest the dividend per share has not fallen, adjusted for stock splits. Only 1% less than the year before counts as a cut, a special dividend in the prior year does not. If the run reaches the start of our data, “at least” is shown.Example: Dividend 1.10 – 0.90 – 0.95 – 1.00 – 1.05 € → 3 years without a cut since the cut.More in the Academy: Lesson debt, dividends and growth
at least 10
as far as the data goes
Growth per year (5 yrs)Dividend growthHow much the dividend per share has risen on average per year, calculated over 5 fiscal years. Only for companies that paid a dividend in the last fiscal year.Example: Dividend €1.00 five years ago, €1.40 today → 7.0% per year.More in the Academy: Lesson debt, dividends and growth
+5.7%
dividend per share, average per year
Coverage by free cash flowDividend coverage by free cash flowFree cash flow per share divided by dividend per share. From 1x, the cash freely available in a year covers the dividend; below that, the company pays out more than is left over. We do not calculate it for the financial sector.Example: Free cash flow €3.00 per share, dividend €2.00 → 1.5x.More in the Academy: Lesson debt, dividends and growth
2.2x
1
covered from 1.0x
You can see the dividend yield and shareholder yield (based on the price) with a free account.Sign up free
More depth
Calculation
Dividend per share: fiscal year 2020 3.16 USD → fiscal year 2025 4.16 USD = +5.7% per year
Free cash flow per share 9.25 USD ÷ dividend per share 4.16 USD = 2.2x
Years without a cut: in a row up to fiscal year 2025, dividend per share according to the SEC, adjusted for stock splits; only 1% less than the year before counts as a cut, also for variable dividends; a special dividend in the prior year does not. If the dividend per share falls while the total paid rises, the run ends as “unclear”. “At least” is shown only if our data ends earlier.
Shareholder yield: dividends paid plus share repurchases minus proceeds from new shares according to the cash flow statement of the last fiscal year, divided by today’s market value. Missing repurchases or new shares count as 0; without reported dividend or repurchase payments (among others for many stocks of the extended selection) there is no value. Describes the reported figures – not investment advice.
Valuation against its own historyWhere P/E, P/S or price/free cash flow stands today compared with the median of the company’s own last 5 fiscal years, in percent. Up to 10% deviation counts as “about at the median”. Describes only the position, not a judgement on an appropriate price.Example: P/E today 22, own 5-year median 27 → 22 ÷ 27 − 1 = −18.5%, so below the median.More in the Academy: Lesson cheaper or pricier than usual?
The P/E is above its own median of the 5 fiscal years before.
With a free account you can see how far – and the same for P/S and price/free cash flow, with the calculation.Sign up free
Source: SEC filings and our daily candles
Dividends and share repurchases
How much the company returns to its shareholders – as dividends or by repurchasing its own shares – and whether free cash flow supports it.
Dividend per share
4.16USD · Fiscal year 2025
Dividend growth per year
3 y+6.1%5 y+5.7%10 y+5.7%
Payout ratio
of earnings71%of free cash flow45%
To shareholders (5 years)
9.3B USD40% through repurchases
Share count over 5 years
+2.2%more shares – dilution
Dividend per share
The dividend per share rose in 5 years from 3.16 USD to 4.16 USD.
Dividend per shareUSD per sharePer share as filed with the SEC, including special dividends; obvious filing errors are hidden.
02.004.006.00
2016Fiscal year 2016: Dividend per share 2.64 USD
2017Fiscal year 2017: Dividend per share 2.92 USD
2018Fiscal year 2018: Dividend per share 3.00 USD
2019Fiscal year 2019: Dividend per share 3.08 USD
2020Fiscal year 2020: Dividend per share 3.16 USD
2021Fiscal year 2021: Dividend per share 3.32 USD
2022Fiscal year 2022: Dividend per share 3.48 USD
2023Fiscal year 2023: Dividend per share 3.64 USD
2024Fiscal year 2024: Dividend per share 3.80 USD
2025Fiscal year 2025: Dividend per share 4.16 USD
Payout ratios
The payout ratio fell in 5 years from 116.6% to 71.5%.
Payout ratio (earnings)Payout ratio (free cash flow)
0%200%400%600%
2016Fiscal year 2016: Payout ratio (earnings) 58.8% · Payout ratio (free cash flow) 30.1%
2017Fiscal year 2017: Payout ratio (earnings) 63.5% · Payout ratio (free cash flow) 37.1%
2018Fiscal year 2018: Payout ratio (earnings) 500.0% · Payout ratio (free cash flow) 47.1%
2019Fiscal year 2019: Payout ratio (earnings) 78.2% · Payout ratio (free cash flow) 41.5%
2020Fiscal year 2020: Payout ratio (earnings) 116.6% · Payout ratio (free cash flow) 37.6%
2021Fiscal year 2021: Payout ratio (earnings) 48.5% · Payout ratio (free cash flow) 30.7%
2022Fiscal year 2022: Payout ratio (earnings) 59.2% · Payout ratio (free cash flow) 72.2%
2023Fiscal year 2023: Payout ratio (earnings) 73.7% · Payout ratio (free cash flow) 52.6%
2024Fiscal year 2024: Payout ratio (earnings) 64.8% · Payout ratio (free cash flow) 35.3%
2025Fiscal year 2025: Payout ratio (earnings) 71.5% · Payout ratio (free cash flow) 44.8%
What goes back to shareholders
Over 5 years, 9.3B USD went back to shareholders, 40% of it through share repurchases. That is 72% of the free cash flow of those years.
2016Fiscal year 2016: Dividends paid 562.0M USD · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow 1.9B USD
2017Fiscal year 2017: Dividends paid 677.0M USD · Share repurchases 220.0M USD · New shares issued (including employee plans) not available · Free cash flow 1.8B USD
2018Fiscal year 2018: Dividends paid 927.0M USD · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow 2.0B USD
2019Fiscal year 2019: Dividends paid 984.0M USD · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow 2.4B USD
2020Fiscal year 2020: Dividends paid 1.0B USD · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow 2.7B USD
2021Fiscal year 2021: Dividends paid 1.0B USD · Share repurchases 1.8B USD · New shares issued (including employee plans) not available · Free cash flow 3.4B USD
2022Fiscal year 2022: Dividends paid 1.1B USD · Share repurchases 500.0M USD · New shares issued (including employee plans) not available · Free cash flow 1.5B USD
2023Fiscal year 2023: Dividends paid 1.1B USD · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow 2.1B USD
2024Fiscal year 2024: Dividends paid 1.1B USD · Share repurchases 500.0M USD · New shares issued (including employee plans) not available · Free cash flow 3.1B USD
2025Fiscal year 2025: Dividends paid 1.2B USD · Share repurchases 1.0B USD · New shares issued (including employee plans) not available · Free cash flow 2.7B USD
Dividends paid, repurchases and new shares issued from the cash flow statement of annual reports filed with the SEC (as first reported). Describes the reported figures – not investment advice.
Valuation over time
Price-based valuation (P/E, P/S, price/free cash flow and dividend yield per fiscal year, compared with its own average) for signed-in users.Log in
Sector comparison
Becton Dickinson next to 8 stocks of the sector Health Care we cover that are closest in revenue. Click a column header to sort the table.
Sector comparison BDX, sector Health Care; last row: sector median
Figures of the last fiscal year from SEC annual reports (peers as of Nov 22, 2026). Median across all companies of the sector we cover (from 5 stocks; several share classes of one company count once). Signed-in users also see P/E, P/S and dividend yield in the comparison. Describes the reported figures – not investment advice.
Key figures with traffic lights
Each light follows a simple, disclosed rule. The comparison is with the sector median Sector medianThe middle value of all companies in a sector: half are above it, half below. Unlike the average, single outliers hardly distort it.Example: Margins 4%, 8%, 10%, 12%, 60% → median 10%, average 18.8%.More in the Academy: Lesson putting the P/E in context of all 26 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).
Revenue growth
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light yellow: below sector
+5.0%per year, last 5 years
Sector Health Care: median +8.5% (25 symbols)
What does this mean? Revenue: over 5 years it grew by 5.0% per year on average, but more slowly than the median company in the sector (+8.5%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
Net income (total)
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light green: above sector
+13.9%per year, last 5 years
Sector Health Care: median +5.5% (20 symbols)
per share: +16.5% per year (5 years, split-adjusted)
What does this mean? Total net income: over 5 years it grew by 13.9% per year on average – at least as fast as the median company in the sector (+5.5%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
What does this mean? Of every 100 USD in revenue, 7.68 USD remained as profit – less than the median company in the sector (13.9%). Five years ago the margin was 5.1%.
Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.
Debt / equity
Debt-to-equity ratioFinancial debt (loans, bonds) divided by equity. A high value amplifies good and bad years alike. The key figures bar in the chart only uses long-term financial debt.Example: Financial debt €300m, equity €500m → 0.6.More in the Academy: Lesson debt, dividends and growth
Light green: lower than sector
0.55latest balance sheet
Sector Health Care: median 0.66 (19 symbols)
What does this mean? For every 1 USD of equity there is 0.55 USD of financial debt – no more than the median company in the sector (0.66). More debt amplifies good and bad years alike.
Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.
Payout ratio
Payout ratioThe share of profit that a company pays out as a dividend. Above 100% it pays out more than it earns.Example: Dividend €1, earnings per share €2.50 → payout ratio 40%.More in the Academy: Lesson debt, dividends and growth
Light yellow: high
71%Dividend / earnings per share
Sector Health Care: median 56% (16 symbols)
What does this mean? Of every 1 USD of earnings per share, 0.71 USD went to shareholders as a dividend. Little buffer remains for weaker years. Median company in the sector: 56%.
Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.
Profitable years
Profitable yearsHow many of the last fiscal years ended with a profit rather than a loss on the bottom line. The figure shows how consistently a company earns.Example: Profit in 9 of 10 years → one loss year.More in the Academy: Lesson revenue, profit and margin
Light green: profit every year
10 of 10fiscal years with a profit
What does this mean? In 10 of the last 10 fiscal years the bottom line showed a profit. There were no losses in this period.
Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).
Last fiscal year and 13F
Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
21.8B USD
Revenue vs. prior year
+8.2%
Net income (FY)
1.7B USD
Net income vs. prior year
−1.6%
EPS (FY)
5.82 USD
Superinvestors holding
3 of 26
Fiscal year to Sep 30, 2025 · 10-K filed Nov 25, 2025 · Balance sheet Jun 30, 2026 (filed Aug 6, 2026) · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term).Superinvestors: 26 tracked investors per 13F filing (as of quarter end, filed up to 45 days later); weight and change per investor in the card “Which superinvestors hold …?”.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
Year
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
2025
Sep 30, 2025
21.8B
1.7B
7.7%
5.82
4.16
71%
2024
Sep 30, 2024
20.2B
1.7B
8.4%
5.86
3.80
65%
2023
Sep 30, 2023
19.4B
1.5B
7.7%
4.94
3.64
74%
2022
Sep 30, 2022
18.9B
1.8B
9.4%
5.88
3.48
59%
2021
Sep 30, 2021
20.2B
2.1B
10.3%
6.85
3.32
48%
2020
Sep 30, 2020
17.1B
874.0M
5.1%
2.71
3.16
117%
2019
Sep 30, 2019
17.3B
1.2B
7.1%
3.94
3.08
78%
2018
Sep 30, 2018
16.0B
311.0M
1.9%
0.60
3.00
500%
2017
Sep 30, 2017
12.1B
1.1B
9.1%
4.60
2.92
63%
2016
Sep 30, 2016
12.5B
976.0M
7.8%
4.49
2.64
59%
Quarters (amounts in USD, per share in USD)
Quarter
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
Q2/26
Jun 30, 2026
5.0B
377.0M
7.6%
1.37
1.05
77%
Q1/26
Mar 31, 2026
4.7B
−311.0M
−6.6%
−1.11
1.05
–
Q4/25
Dec 31, 2025
5.3B
382.0M
7.3%
1.34
1.05
78%
Q3/25*
Sep 30, 2025
5.9B
493.0M
8.4%
–
–
–
Q2/25
Jun 30, 2025
5.5B
574.0M
10.4%
2.00
1.04
52%
Q1/25
Mar 31, 2025
5.3B
308.0M
5.8%
1.07
1.04
97%
Q4/24
Dec 31, 2024
5.2B
303.0M
5.9%
1.04
1.04
100%
Q3/24*
Sep 30, 2024
5.4B
400.0M
7.4%
–
–
–
Q2/24
Jun 30, 2024
5.0B
487.0M
9.8%
1.68
0.95
57%
Q1/24
Mar 31, 2024
5.0B
537.0M
10.6%
1.85
0.95
51%
Q4/23
Dec 31, 2023
4.7B
281.0M
6.0%
0.96
0.95
99%
Q3/23*
Sep 30, 2023
5.1B
108.0M
2.1%
–
–
–
* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.
How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.
Information only – does not affect the other analysis methods, not investment advice.
Insiders
Insider transactionsExecutives, directors and major shareholders (over 10%) of US companies report their own transactions in their company’s stock to the SEC within two business days (Form 4). Purchases in the market count as more meaningful than sales (often taxes, estate planning).Example: Three executives acquire stock worth a total of 2 million USD within two weeks → “purchases by several insiders”.More in the Academy: Glossary
Aug 26, 2026Feld MichaelOfficerOpen-market sale · 10b5-1 plan165 shares · $31.1K · SEC
Aug 13, 2026Polen Thomas E JrChief executive (CEO), DirectorOpen-market sale · 10b5-1 plan4,152 shares · $768.1K · SEC
Aug 11, 2026Goette RolandOfficerOpen-market sale2,438 shares · $440.9K · SEC
Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.
Which superinvestors hold Becton Dickinson?
Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
Source: 13F filing with the US Securities and Exchange Commission, latest filing dated Nov 16, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.
Trend score –
We do not calculate a trend score for symbols in the extended universe.
Volatility and trend strength
ADX 14 (trend strength)–
Price change 60 days–
ATR ATR (Average True Range)The average range per trading day over the last 14 days. It makes distances comparable, whether a stock costs 10 or 1,000.Example: ATR 2.50 at a price of 100: 0.4 ATR is 1.00, i.e. 1%.More in the Academy: Lesson ATR and moving averages as price values only when logged in.